Ravikumar Balasubramanian1, Sheena Chew, Sarah E MacKinnon, Peter B Kang, Caroline Andrews, Wai-Man Chan, Elizabeth C Engle. 1. Harvard Reproductive Endocrine Sciences Center (R.B.), The Reproductive Endocrine Unit of the Department of Medicine (R.B.), Massachusetts General Hospital, Boston, Massachusetts 02114; Harvard Medical School (R.B., S.C., P.B.K., C.A., W.-M.C., E.C.E.), Boston, Massachusetts 02115; Department of Neurology (S.C., P.B.K., C.A., W.-M.C., E.C.E.), Kirby Neurobiology Center (S.C., C.A., W.-M.C., E.C.E.), and Department of Ophthalmology (S.E.M., E.C.E.), Boston Children's Hospital, Boston, Massachusetts 02115; and Howard Hughes Medical Institute (S.C., C.A., W.-M.C., E.C.E.), Chevy Chase, Maryland 20815.
Abstract
CONTEXT: A heterozygous de novo c.1228G>A mutation (E410K) in the TUBB3 gene encoding the neuronal-specific β-tubulin isotype 3 (TUBB3) causes the TUBB3 E410K syndrome characterized by congenital fibrosis of the extraocular muscles (CFEOM), facial weakness, intellectual and social disabilities, and Kallmann syndrome (anosmia with hypogonadotropic hypogonadism). All TUBB3 E410K subjects reported to date are sporadic cases. OBJECTIVE: This study aimed to report the clinical, genetic, and molecular features of a familial presentation of the TUBB3 E410K syndrome. DESIGN: Case report of a mother and three affected children with clinical features of the TUBB3 E410K syndrome. SETTING: Academic Medical Center. MAIN OUTCOME MEASURES: Genetic analysis of the TUBB3 gene and clinical evaluation of endocrine and nonendocrine phenotypes. RESULTS: A de novo TUBB3 c.1228G>A mutation arose in a female proband who displayed CFEOM, facial weakness, intellectual and social disabilities, and anosmia. However, she underwent normal sexual development at puberty and had three spontaneous pregnancies with subsequent autosomal-dominant inheritance of the mutation by her three boys. All sons displayed nonendocrine features of the TUBB3 E410K syndrome similar to their mother but, in addition, had variable features suggestive of additional endocrine abnormalities. CONCLUSIONS: This first report of an autosomal-dominant inheritance of the TUBB3 c.1228G>A mutation in a family provides new insights into the spectrum and variability of endocrine phenotypes associated with the TUBB3 E410K syndrome. These observations emphasize the need for appropriate clinical evaluation and complicate genetic counseling of patients and families with this syndrome.
CONTEXT: A heterozygous de novo c.1228G>A mutation (E410K) in the TUBB3 gene encoding the neuronal-specific β-tubulin isotype 3 (TUBB3) causes the TUBB3E410K syndrome characterized by congenital fibrosis of the extraocular muscles (CFEOM), facial weakness, intellectual and social disabilities, and Kallmann syndrome (anosmia with hypogonadotropic hypogonadism). All TUBB3E410K subjects reported to date are sporadic cases. OBJECTIVE: This study aimed to report the clinical, genetic, and molecular features of a familial presentation of the TUBB3E410K syndrome. DESIGN: Case report of a mother and three affected children with clinical features of the TUBB3E410K syndrome. SETTING: Academic Medical Center. MAIN OUTCOME MEASURES: Genetic analysis of the TUBB3 gene and clinical evaluation of endocrine and nonendocrine phenotypes. RESULTS: A de novo TUBB3 c.1228G>A mutation arose in a female proband who displayed CFEOM, facial weakness, intellectual and social disabilities, and anosmia. However, she underwent normal sexual development at puberty and had three spontaneous pregnancies with subsequent autosomal-dominant inheritance of the mutation by her three boys. All sons displayed nonendocrine features of the TUBB3E410K syndrome similar to their mother but, in addition, had variable features suggestive of additional endocrine abnormalities. CONCLUSIONS: This first report of an autosomal-dominant inheritance of the TUBB3 c.1228G>A mutation in a family provides new insights into the spectrum and variability of endocrine phenotypes associated with the TUBB3E410K syndrome. These observations emphasize the need for appropriate clinical evaluation and complicate genetic counseling of patients and families with this syndrome.
Authors: Rachel Reynaud; Sujatha A Jayakody; Carine Monnier; Alexandru Saveanu; Jérome Bouligand; Anne-Marie Guedj; Gilbert Simonin; Pierre Lecomte; Anne Barlier; Philippe Rondard; Juan Pedro Martinez-Barbera; Anne Guiochon-Mantel; Thierry Brue Journal: J Clin Endocrinol Metab Date: 2012-03-30 Impact factor: 5.958
Authors: Nelly Pitteloud; Astrid Meysing; Richard Quinton; James S Acierno; Andrew A Dwyer; Lacey Plummer; Eric Fliers; Paul Boepple; Frances Hayes; Stephanie Seminara; Viriginia A Hughes; Jinghong Ma; Pierre Bouloux; Moosa Mohammadi; William F Crowley Journal: Mol Cell Endocrinol Date: 2006-06-09 Impact factor: 4.102
Authors: Ravikumar Balasubramanian; Andrew Dwyer; Stephanie B Seminara; Nelly Pitteloud; Ursula B Kaiser; William F Crowley Journal: Neuroendocrinology Date: 2010-07-07 Impact factor: 4.914
Authors: Gerasimos P Sykiotis; Lacey Plummer; Virginia A Hughes; Margaret Au; Sadia Durrani; Sadhana Nayak-Young; Andrew A Dwyer; Richard Quinton; Janet E Hall; James F Gusella; Stephanie B Seminara; William F Crowley; Nelly Pitteloud Journal: Proc Natl Acad Sci U S A Date: 2010-08-09 Impact factor: 11.205
Authors: Taneli Raivio; John Falardeau; Andrew Dwyer; Richard Quinton; Frances J Hayes; Virginia A Hughes; Lindsay W Cole; Simon H Pearce; Hang Lee; Paul Boepple; William F Crowley; Nelly Pitteloud Journal: N Engl J Med Date: 2007-08-30 Impact factor: 91.245
Authors: Valerie F Sidhoum; Yee-Ming Chan; Margaret F Lippincott; Ravikumar Balasubramanian; Richard Quinton; Lacey Plummer; Andrew Dwyer; Nelly Pitteloud; Frances J Hayes; Janet E Hall; Kathryn A Martin; Paul A Boepple; Stephanie B Seminara Journal: J Clin Endocrinol Metab Date: 2013-01-01 Impact factor: 5.958
Authors: John Falardeau; Wilson C J Chung; Andrew Beenken; Taneli Raivio; Lacey Plummer; Yisrael Sidis; Elka E Jacobson-Dickman; Anna V Eliseenkova; Jinghong Ma; Andrew Dwyer; Richard Quinton; Sandra Na; Janet E Hall; Celine Huot; Natalie Alois; Simon H S Pearce; Lindsay W Cole; Virginia Hughes; Moosa Mohammadi; Pei Tsai; Nelly Pitteloud Journal: J Clin Invest Date: 2008-08 Impact factor: 14.808
Authors: Lindsay W Cole; Yisrael Sidis; ChengKang Zhang; Richard Quinton; Lacey Plummer; Duarte Pignatelli; Virginia A Hughes; Andrew A Dwyer; Taneli Raivio; Frances J Hayes; Stephanie B Seminara; Celine Huot; Nathalie Alos; Phyllis Speiser; Akira Takeshita; Guy Van Vliet; Simon Pearce; William F Crowley; Qun-Yong Zhou; Nelly Pitteloud Journal: J Clin Endocrinol Metab Date: 2008-06-17 Impact factor: 5.958
Authors: Mervyn G Thomas; Gail D E Maconachie; Helen J Kuht; Wai-Man Chan; Viral Sheth; Michael Hisaund; Rebecca J McLean; Brenda Barry; Bashir Al-Diri; Frank A Proudlock; Zhanhan Tu; Elizabeth C Engle; Irene Gottlob Journal: Int J Mol Sci Date: 2021-03-04 Impact factor: 5.923